Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
54
RNA Quote, Financials, Valuation and Earnings
Last price:
$72.19
Seasonality move
:
29.53%
Day range:
$72.05 - $72.19
52-week range:
$21.51 - $72.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
453.94x
P/B ratio:
5.76x
Volume:
1.2M
Avg. volume:
2.8M
1-year change:
128%
Market cap:
$10.9B
Revenue:
$10.9M
EPS (TTM):
-$4.17
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.8M | $9.3M | $9.2M | $9.6M | $10.9M | |
| Revenue Growth (YoY) | 192.67% | 37.41% | -1.09% | 3.64% | 13.99% | |
| Cost of Revenues | -- | $639K | $1.4M | $2.1M | $2.8M | |
| Gross Profit | -- | $8.7M | $7.8M | $7.5M | $8.1M | |
| Gross Profit Margin | -- | 93.15% | 84.96% | 78.02% | 74.53% | |
| R&D Expenses | $37.6M | $101.2M | $150.4M | $191M | $303.6M | |
| Selling, General & Admin | $13.5M | $26.2M | $37.7M | $54.2M | $86.2M | |
| Other Inc / (Exp) | -$75K | -$62K | -$57K | -$594K | -$248K | |
| Operating Expenses | $44.3M | $126.7M | $186.8M | $243.1M | $387.1M | |
| Operating Income | -$44.3M | -$118.1M | -$178.9M | -$235.6M | -$378.9M | |
| Net Interest Expenses | $209K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$44.4M | -$118M | -$174M | -$212.2M | -$322.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$44.4M | -$118M | -$174M | -$212.2M | -$322.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$44.4M | -$118M | -$174M | -$212.2M | -$322.3M | |
| Basic EPS (Cont. Ops) | -$2.05 | -$2.85 | -$3.34 | -$2.91 | -$2.89 | |
| Diluted EPS (Cont. Ops) | -$2.05 | -$2.85 | -$3.34 | -$2.91 | -$2.89 | |
| Weighted Average Basic Share | $21.7M | $41.4M | $52.2M | $73M | $111.6M | |
| Weighted Average Diluted Share | $21.7M | $41.4M | $52.2M | $73M | $111.6M | |
| EBITDA | -$43.9M | -$117.4M | -$177.5M | -$233.5M | -$376.2M | |
| EBIT | -$44.3M | -$118.1M | -$178.9M | -$235.6M | -$378.9M | |
| Revenue (Reported) | $6.8M | $9.3M | $9.2M | $9.6M | $10.9M | |
| Operating Income (Reported) | -$44.3M | -$118.1M | -$178.9M | -$235.6M | -$378.9M | |
| Operating Income (Adjusted) | -$44.3M | -$118.1M | -$178.9M | -$235.6M | -$378.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2M | $2.5M | $2.8M | $2.3M | $12.5M | |
| Revenue Growth (YoY) | 23.88% | 14.75% | 13.54% | -17.1% | 434.03% | |
| Cost of Revenues | -- | $400K | $1.3M | $710K | $1.1M | |
| Gross Profit | -- | $2.1M | $1.5M | $1.6M | $11.4M | |
| Gross Profit Margin | -- | 83.88% | 53.87% | 69.61% | 91.54% | |
| R&D Expenses | $24.8M | $37.3M | $47.7M | $77.2M | $154.9M | |
| Selling, General & Admin | $6.6M | $10.1M | $13.7M | $23.3M | $46.3M | |
| Other Inc / (Exp) | -$11K | -$12K | -$13K | -$232K | -- | |
| Operating Expenses | $29.3M | $47M | $60.1M | $99.8M | $200.2M | |
| Operating Income | -$29.3M | -$44.9M | -$58.6M | -$98.1M | -$188.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$29.3M | -$43.6M | -$52.4M | -$80.4M | -$174.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$29.3M | -$43.6M | -$52.4M | -$80.4M | -$174.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$29.3M | -$43.6M | -$52.4M | -$80.4M | -$174.4M | |
| Basic EPS (Cont. Ops) | -$0.68 | -$0.82 | -$0.71 | -$0.65 | -$1.27 | |
| Diluted EPS (Cont. Ops) | -$0.68 | -$0.82 | -$0.71 | -$0.65 | -$1.27 | |
| Weighted Average Basic Share | $43.3M | $53.1M | $74.1M | $123.4M | $137.9M | |
| Weighted Average Diluted Share | $43.3M | $53.1M | $74.1M | $123.4M | $137.9M | |
| EBITDA | -$29.1M | -$44.5M | -$57.3M | -$97.4M | -$187.8M | |
| EBIT | -$29.3M | -$44.9M | -$58.6M | -$98.1M | -$188.8M | |
| Revenue (Reported) | $2.2M | $2.5M | $2.8M | $2.3M | $12.5M | |
| Operating Income (Reported) | -$29.3M | -$44.9M | -$58.6M | -$98.1M | -$188.8M | |
| Operating Income (Adjusted) | -$29.3M | -$44.9M | -$58.6M | -$98.1M | -$188.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.6M | $8.3M | $10.1M | $10.1M | $20.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $1.2M | $4M | $2.7M | $3.4M | |
| Gross Profit | -- | $7.1M | $6.1M | $7.5M | $17.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $81.8M | $137.8M | $183.8M | $260.8M | $488.2M | |
| Selling, General & Admin | $23.6M | $34.8M | $48.5M | $74M | $145.1M | |
| Other Inc / (Exp) | -$16K | -$85K | -$507K | -$554K | -- | |
| Operating Expenses | $95.8M | $171.3M | $228.2M | $332.2M | $629.9M | |
| Operating Income | -$95.8M | -$164.2M | -$222.1M | -$324.7M | -$612.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$95.7M | -$162.1M | -$202.2M | -$280.5M | -$549.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$95.7M | -$162.1M | -$202.2M | -$280.5M | -$549.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$95.7M | -$162.1M | -$202.2M | -$280.5M | -$549.8M | |
| Basic EPS (Cont. Ops) | -$2.45 | -$3.26 | -$2.99 | -$2.90 | -$4.17 | |
| Diluted EPS (Cont. Ops) | -$2.45 | -$3.26 | -$2.99 | -$2.90 | -$4.17 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$95.2M | -$163M | -$218.1M | -$322M | -$609.1M | |
| EBIT | -$95.8M | -$164.2M | -$222.1M | -$324.7M | -$612.5M | |
| Revenue (Reported) | $9.6M | $8.3M | $10.1M | $10.1M | $20.9M | |
| Operating Income (Reported) | -$95.8M | -$164.2M | -$222.1M | -$324.7M | -$612.5M | |
| Operating Income (Adjusted) | -$95.8M | -$164.2M | -$222.1M | -$324.7M | -$612.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $7.5M | $6.5M | $7.4M | $7.9M | $17.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $1M | $3.6M | $2M | $2.7M | |
| Gross Profit | -- | $5.4M | $3.7M | $5.9M | $15.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $68.2M | $104.8M | $138.2M | $208M | $392.6M | |
| Selling, General & Admin | $18.8M | $27.3M | $38.1M | $57.9M | $116.8M | |
| Other Inc / (Exp) | -$16K | -$39K | -$489K | -$449K | -$1.1M | |
| Operating Expenses | $79.5M | $131.1M | $172.6M | $263.8M | $506.7M | |
| Operating Income | -$79.5M | -$125.7M | -$168.9M | -$257.9M | -$491.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$79.5M | -$123.5M | -$151.8M | -$220M | -$447.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$79.5M | -$123.5M | -$151.8M | -$220M | -$447.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$79.5M | -$123.5M | -$151.8M | -$220M | -$447.5M | |
| Basic EPS (Cont. Ops) | -$2.01 | -$2.45 | -$2.11 | -$2.10 | -$3.37 | |
| Diluted EPS (Cont. Ops) | -$2.01 | -$2.45 | -$2.11 | -$2.10 | -$3.37 | |
| Weighted Average Basic Share | $118.4M | $151.2M | $215.9M | $317.5M | $396.7M | |
| Weighted Average Diluted Share | $118.4M | $151.2M | $215.9M | $317.5M | $396.7M | |
| EBITDA | -$79M | -$124.7M | -$165.2M | -$255.9M | -$488.8M | |
| EBIT | -$79.5M | -$125.7M | -$168.9M | -$257.9M | -$491.5M | |
| Revenue (Reported) | $7.5M | $6.5M | $7.4M | $7.9M | $17.9M | |
| Operating Income (Reported) | -$79.5M | -$125.7M | -$168.9M | -$257.9M | -$491.5M | |
| Operating Income (Adjusted) | -$79.5M | -$125.7M | -$168.9M | -$257.9M | -$491.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $328.1M | $405.5M | $610.7M | $595.4M | $1.5B | |
| Short Term Investments | $6.7M | $85.1M | $270.3M | $410.3M | $1.3B | |
| Accounts Receivable, Net | $1.2M | $900K | $2.1M | $1.9M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | $8.3M | $7.3M | $12.6M | |
| Other Current Assets | $3.5M | $5.6M | -- | -- | -- | |
| Total Current Assets | $331.7M | $411.1M | $622.9M | $611.3M | $1.5B | |
| Property Plant And Equipment | $1.9M | $15.6M | $15M | $16.7M | $18.3M | |
| Long-Term Investments | $251K | $251K | $251K | $295K | $2.8M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $298K | $850K | $849K | $596K | $3.3M | |
| Total Assets | $333.9M | $427.6M | $638.8M | $628.6M | $1.6B | |
| Accounts Payable | $7.7M | $14.1M | $32.6M | $8.8M | $8.5M | |
| Accrued Expenses | -- | $11.3M | $27.9M | $25.5M | $61.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $1.8M | $3.1M | $3.6M | $3.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $14.6M | $29.7M | $51.9M | $80.7M | $98M | |
| Long-Term Debt | $938K | $10M | $7.6M | $6.2M | $3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $27.7M | $46.2M | $60.7M | $127.8M | $138.9M | |
| Common Stock | $4K | $5K | $7K | $8K | $12K | |
| Other Common Equity Adj | -$5K | -$187K | -$2.7M | $125K | $2.9M | |
| Common Equity | $306.2M | $381.4M | $578.1M | $500.8M | $1.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $306.2M | $381.4M | $578.1M | $500.8M | $1.4B | |
| Total Liabilities and Equity | $333.9M | $427.6M | $638.8M | $628.6M | $1.6B | |
| Cash and Short Terms | $328.1M | $405.5M | $610.7M | $595.4M | $1.5B | |
| Total Debt | $938K | $10M | $7.6M | $6.2M | $3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $413M | $405.5M | $542.6M | $1.6B | $1.9B | |
| Short Term Investments | $3M | $261.8M | $456.9M | $1.2B | -- | |
| Accounts Receivable, Net | $900K | $1.3M | $1M | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | $14.1M | $15.2M | |
| Other Current Assets | $8.9M | $8.9M | $12.9M | -- | -- | |
| Total Current Assets | $422M | $414.5M | $555.5M | $1.6B | $2B | |
| Property Plant And Equipment | $3.3M | $15.3M | $17M | $15.8M | $74.4M | |
| Long-Term Investments | $251K | $251K | $295K | $2.8M | $2.8M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $739K | $774K | $639K | $3.1M | -- | |
| Total Assets | $425.9M | $430.5M | $573.2M | $1.6B | $2.1B | |
| Accounts Payable | $11.9M | $26.4M | $32M | $7.7M | $9.6M | |
| Accrued Expenses | -- | -- | $26.4M | $42M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $3.1M | $3.6M | $3.8M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $22.4M | $42.7M | $48.7M | $91.3M | $169.9M | |
| Long-Term Debt | $877K | $8.2M | $7M | $3.8M | $46M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $31M | $53.6M | $55.7M | $137.4M | $247.9M | |
| Common Stock | $5K | $5K | $7K | $12K | $15K | |
| Other Common Equity Adj | -$1K | -$3.5M | -$1.9M | $7.1M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -$141.4M | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $394.9M | $377M | $517.5M | $1.5B | $1.9B | |
| Total Liabilities and Equity | $425.9M | $430.5M | $573.2M | $1.6B | $2.1B | |
| Cash and Short Terms | $413M | $405.5M | $542.6M | $1.6B | $1.9B | |
| Total Debt | $877K | $8.2M | $7M | $3.8M | $46M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$44.4M | -$118M | -$174M | -$212.2M | -$322.3M | |
| Depreciation & Amoritzation | $373K | $639K | $1.4M | $2.1M | $2.8M | |
| Stock-Based Compensation | $4.3M | $17.1M | $27.1M | $38.2M | $51.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$37.1M | -$94.8M | -$136.3M | -$119.1M | -$300.9M | |
| Capital Expenditures | $1.1M | $3.7M | $2.8M | $4.2M | $7.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$7.8M | -$82.5M | -$190M | -$130.1M | -$854.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$4.7M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $272M | $176.3M | $346.2M | $93.9M | $1.2B | |
| Beginning Cash (CF) | $321.5M | $320.4M | $340.4M | $185.1M | $219.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $227.1M | -$1M | $19.9M | -$155.3M | $37.3M | |
| Ending Cash (CF) | $548.6M | $319.4M | $360.3M | $29.8M | $257.2M | |
| Levered Free Cash Flow | -$38.2M | -$98.6M | -$139.1M | -$123.3M | -$307.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$29.3M | -$43.6M | -$52.4M | -$80.4M | -$174.4M | |
| Depreciation & Amoritzation | $176K | $370K | $1.3M | $710K | $1.1M | |
| Stock-Based Compensation | $4.6M | $7.1M | $9.8M | $14.1M | $19M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$20.8M | -$32M | -$36.8M | -$65.6M | -$156.2M | |
| Capital Expenditures | $800K | -$107K | $923K | $1.7M | $712K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$800K | $10.9M | -$31.5M | -$482.4M | -$587.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$10.5M | -- | -- | -- | -- | |
| Cash From Financing | $155.2M | $39.6M | $40K | $342.5M | $850.4M | |
| Beginning Cash (CF) | $410M | $143.7M | $85.7M | $370.2M | $350.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -$16K | |
| Additions / Reductions | $133.6M | $18.6M | -$68.2M | -$205.6M | $106.3M | |
| Ending Cash (CF) | $543.6M | $162.3M | $17.4M | $164.6M | $456.4M | |
| Levered Free Cash Flow | -$21.6M | -$31.9M | -$37.7M | -$67.3M | -$156.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$95.7M | -$162.1M | -$202.2M | -$280.5M | -$549.8M | |
| Depreciation & Amoritzation | $546K | $1.2M | $4M | $499K | $3.4M | |
| Stock-Based Compensation | $14.4M | $24.3M | $35.7M | $47.1M | $68.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$81.7M | -$123.2M | -$174.8M | -$184.5M | -$580.5M | |
| Capital Expenditures | $2.3M | $3.7M | $4.2M | $4M | $11.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$5.4M | -$266.3M | -$188.9M | -$739M | -$309.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $156.1M | $123.2M | $305.6M | $1.2B | $869.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $69M | -$266.3M | -$58M | $287M | -$20M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$84M | -$126.9M | -$179M | -$188.5M | -$592.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$79.5M | -$123.5M | -$151.8M | -$220M | -$447.5M | |
| Depreciation & Amoritzation | $431K | $1M | $3.6M | $2M | $2.7M | |
| Stock-Based Compensation | $12.5M | $19.8M | $28.4M | $37.2M | $54.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$68.7M | -$97.1M | -$135.6M | -$201M | -$480.7M | |
| Capital Expenditures | $2M | $2M | $3.4M | $3.2M | $7.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $1.5M | -$182.2M | -$181.1M | -$790M | -$245.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$10.5M | -- | -- | -- | -- | |
| Cash From Financing | $155.7M | $102.5M | $62M | $1.2B | $856.1M | |
| Beginning Cash (CF) | $987.7M | $408.1M | $358.2M | $1.4B | $848.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -$16K | |
| Additions / Reductions | $88.6M | -$176.7M | -$254.7M | $187.6M | $130.3M | |
| Ending Cash (CF) | $1.1B | $231.3M | $103.5M | $1.6B | $978.5M | |
| Levered Free Cash Flow | -$70.7M | -$99.1M | -$138.9M | -$204.1M | -$488.5M | |
Get RNA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RNA
Sector
P/E ratio
--
23.89x
PEG ratio
-0.39x
-0.01x
P/B ratio
5.76x
1.81x
Price / LTM sales
453.94x
1.59x
Growth Metrics
RNA
Sector
Revenue growth
434.03%
4.62%
Earnings growth
-94.11%
11.06%
Revenue (5-year growth)
36.27%
6.5%
Earnings forecast
-$1.10
-$0.21
Profitability
RNA
Sector
Profitability FY 2024
$8.1M
$3.6M
Return on invested capital
-37.09%
-31.84%
Return on assets
-33.66%
-27.96%
Return on equity
-37.47%
-37.63%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
2
Estimated Next Earnings Date
Feb
9
Balance Sheet
RNA
Sector
Total cash
$1.9B
$26.4M
Short term investments
$1.3B
$25.7M
Total assets
$1.6B
$76.9M
Long term debt
$46M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
